Literature DB >> 32336846

Trace Metals Screening Process of Devices Used for the Collection, Analysis, and Storage of Biological Specimens.

Cynthia D Ward1,2, Reba J Williams1, Katelyn Mullenix2, Kristy Syhapanha2, Robert L Jones1, Kathleen Caldwell1.   

Abstract

The Centers for Disease Control and Prevention's (CDC) Environmental Health Laboratory uses modified versions of inductively coupled plasma mass spectrometry (ICP-MS) analytical methods to quantify metals contamination present in items that will come into contact with patient samples during the pre-analytical, analytical, and post-analytical stages. This lot screening process allows us to reduce the likelihood of introducing contamination which can lead to falsely elevated results. This is particularly important when looking at biomonitoring levels in humans which tend to be near the limit of detection of many methods. The fundamental requirements for a lot screening program in terms of facilities and processes are presented along with a discussion of sample preparation techniques used for lot screening. The criteria used to evaluate the lot screening data to determine the acceptability of a particular manufacturing lot is presented as well. As a result of lot testing, unsuitable manufactured lots are identified and excluded from use.

Entities:  

Year:  2018        PMID: 32336846      PMCID: PMC7181901     

Source DB:  PubMed          Journal:  At Spectrosc        ISSN: 0195-5373            Impact factor:   2.042


  4 in total

1.  Assessment of the contamination from devices used for sampling and storage of whole blood and serum for element analysis.

Authors:  I Rodushkin; F Odman
Journal:  J Trace Elem Med Biol       Date:  2001       Impact factor: 3.849

2.  Measurement Challenges at Low Blood Lead Levels.

Authors:  Kathleen L Caldwell; Po-Yung Cheng; Jeffery M Jarrett; Amir Makhmudov; Kathryn Vance; Cynthia D Ward; Robert L Jones; Mary E Mortensen
Journal:  Pediatrics       Date:  2017-07-17       Impact factor: 7.124

3.  Analysis of whole human blood for Pb, Cd, Hg, Se, and Mn by ICP-DRC-MS for biomonitoring and acute exposures.

Authors:  Deanna R Jones; Jeffery M Jarrett; Denise S Tevis; Melanie Franklin; Neva J Mullinix; Kristen L Wallon; C Derrick Quarles; Kathleen L Caldwell; Robert L Jones
Journal:  Talanta       Date:  2016-09-28       Impact factor: 6.057

4.  Analytical considerations in the clinical laboratory assessment of metals.

Authors:  Richard Y Wang; Kathleen L Caldwell; Robert L Jones
Journal:  J Med Toxicol       Date:  2014-06
  4 in total
  3 in total

1.  Importance of Preanalytical Factors in Measuring Cr and Co Levels in Human Whole Blood: Contamination Control, Proper Sample Collection and Long-Term Storage Stability.

Authors:  Yuliya L Sommer; Cynthia D Ward; Joaudimir Castro Georgi; Po-Yung Cheng; Robert L Jones
Journal:  J Anal Toxicol       Date:  2021-03-12       Impact factor: 3.367

2.  Development and validation of a biomonitoring method to measure As, Cr, and Ni in human urine samples by ICP-UCT-MS.

Authors:  Deanna R Jones; Jeffery M Jarrett; Danielle Stukes; Adam Baer; Megan McMichael; Kristen Wallon; Ge Xiao; Robert L Jones
Journal:  Int J Hyg Environ Health       Date:  2021-02-20       Impact factor: 5.840

3.  Vitamin D Treatment during Pregnancy and Maternal and Neonatal Cord Blood Metal Concentrations at Delivery: Results of a Randomized Controlled Trial in Bangladesh.

Authors:  Anne Marie Z Jukic; Anna Zuchniak; Huma Qamar; Tahmeed Ahmed; Abdullah Al Mahmud; Daniel E Roth
Journal:  Environ Health Perspect       Date:  2020-11-23       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.